Related Experiment Video
Updated: Aug 4, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
PPAR-γ Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1α/Δψ m Pathways by Inhibiting
Zhencheng Feng1, Qiuxiang Huang2, Xingliang Zhang3,4
1Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou 51022, China.
Abstract:
Osteoarthritis (OA) is a common degenerative joint disease with a gradually increasing morbidity in the aging and obese population. Emerging evidence has implicated pyroptosis in the etiology of OA and it may be recognized as a therapeutic target in OA. We have previously reported regarding another disease that peroxisome proliferator-activated receptor gamma (PPAR-γ) activation exerts an anti-inflammatory effect by suppressing the nucleotide-binding and oligomerization domain-like receptor containing protein (NLRP) 3 inflammasome. However, the relationship between PPAR-γ and NLRP3-mediated pyroptosis in OA cartilage and its underlying mechanisms is fully unclear. In this study, we found that the level of NLRP3-mediated pyroptosis in severe lateral femoral condyle cartilage wear in the knee of an OA patient was significantly higher than that in the mild lateral femoral condyle cartilage wear areas. Moreover, in lipopolysaccharide (LPS)/adenosine triphosphate (ATP)-induced primary chondrocytes and knee OA rat models, we demonstrated that activation of PPAR-γ by pioglitazone (Piog) attenuated LPS/ATP-induced chondrocyte pyroptosis and arthritis. These effects were partially counteracted by either blocking the nuclear factor erythroid-2-related factor (Nrf2)/NLRP3 or PGC1-α/Δψ m signaling pathway. Simultaneous depression of these two signaling pathways can completely abrogate the protective effects of Piog on OA and chondrocytes. Taken together, Piog protects OA cartilage against pyroptosis-induced damage by simultaneously activating both the Nrf2/NLRP3 and PGC-1α/Δψ m pathways, which enhances antioxidative and anti-inflammatory responses as well as mitochondrial biogenesis. Therefore, Piog may be a promising agent for human OA cartilage damage in future clinical treatments.
Insights
Pioglitazone (Piog) activation of PPAR-gamma suppresses pyroptosis in osteoarthritis (OA) cartilage by enhancing Nrf2/NLRP3 and PGC1-alpha/Δψm pathways, offering a potential treatment for OA.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease with increasing incidence in aging and obese populations.
- Emerging evidence suggests pyroptosis plays a role in OA pathogenesis, identifying it as a potential therapeutic target.
- The precise relationship between peroxisome proliferator-activated receptor gamma (PPAR-γ) and NLRP3-mediated pyroptosis in OA cartilage remains unclear.
Purpose of the Study:
- To investigate the role of PPAR-γ in regulating NLRP3-mediated pyroptosis in OA cartilage.
- To elucidate the underlying molecular mechanisms connecting PPAR-γ activation to pyroptosis suppression in OA.
- To evaluate the therapeutic potential of pioglitazone (Piog) in OA models.
Main Methods:
- Analysis of NLRP3-mediated pyroptosis levels in human OA cartilage samples with varying severity.
- In vitro studies using lipopolysaccharide (LPS)/adenosine triphosphate (ATP)-induced primary chondrocytes.
- In vivo studies utilizing knee OA rat models.
- Pharmacological intervention with pioglitazone (Piog) and pathway inhibitors (Nrf2/NLRP3, PGC1-α/Δψm).
Main Results:
- Higher levels of NLRP3-mediated pyroptosis were observed in severe OA cartilage compared to mild OA cartilage.
- Pioglitazone (Piog) activation of PPAR-γ attenuated LPS/ATP-induced chondrocyte pyroptosis and arthritis in rat models.
- The protective effects of Piog were partially reversed by inhibiting the Nrf2/NLRP3 or PGC-1α/Δψm pathways.
- Complete abrogation of Piog's protective effects occurred when both pathways were simultaneously inhibited.
Conclusions:
- Pioglitazone (Piog) protects OA cartilage from pyroptosis-induced damage by simultaneously activating the Nrf2/NLRP3 and PGC-1α/Δψm signaling pathways.
- These activated pathways enhance antioxidative and anti-inflammatory responses and promote mitochondrial biogenesis.
- Pioglitazone (Piog) shows promise as a potential therapeutic agent for human OA cartilage damage.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
GPCRs Regulate Adenylyl Cylase Activity
The JAK-STAT Signaling Pathway
Co-activators and Co-repressors
Regulation of the Unfolded Protein Response
TGF - β Signaling Pathway

